14:58 EST Revolution Medicines (RVMD) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Revolution Medicines near deal to be bought by AbbVie, WSJ says
- AbbVie near deal to buy Revolution Medicines, WSJ reports
- Revolution Medicines trading halted, volatility trading pause
- Erasca initiated with an Overweight at Piper Sandler
- Revolution Medicines price target raised to $98 from $82 at BofA